Search research articles
Contact Us
Filters
Showing results (21-30 of 47) with videos related to
Page
of 5
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
January 5, 2010
An octahydro-cyclopenta[c]pyrrole series of inhibitors of the type 1 glycine transporter
John A Lowe, Shari L Deninno, Susan E Drozda, et al.
ACS Chemical Biology
|
October 9, 2014
Chemoproteomics demonstrates target engagement and exquisite selectivity of the clinical phosphodiesterase 10A inhibitor MP-10 in its native environment
Jan-Philip Schülke, Laura A McAllister, Kieran F Geoghegan, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
July 26, 2006
Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species
Timothy M Coskran, Daniel Morton, Frank S Menniti, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 10, 2015
Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways
Fernando E Padovan-Neto, Stephen Sammut, Shreaya Chakroborty, et al.
Neuropharmacology
|
June 20, 2006
Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis
Judith A Siuciak, Douglas S Chapin, John F Harms, et al.
Brain Research
|
January 22, 2019
In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [<sup>18</sup>F]MNI-659
Marie M Svedberg, Katarina Varnäs, Andrea Varrone, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 7, 2010
Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's disease
Robin J Kleiman, Lida H Kimmel, Susan E Bove, et al.
Neuropharmacology
|
June 14, 2006
Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function
Judith A Siuciak, Sheryl A McCarthy, Douglas S Chapin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 2013
Positive allosteric modulation of AMPA receptors from efficacy to toxicity: the interspecies exposure-response continuum of the novel potentiator PF-4778574
Christopher L Shaffer, Raymond S Hurst, Renato J Scialis, et al.
Journal of Medicinal Chemistry
|
January 19, 2007
Discovery of a series of 6,7-dimethoxy-4-pyrrolidylquinazoline PDE10A inhibitors
Thomas A Chappie, John M Humphrey, Martin P Allen, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 47) with videos related to
Sort By:
Page
of 5
Bioorganic & Medicinal Chemistry Letters
|
January 5, 2010
An octahydro-cyclopenta[c]pyrrole series of inhibitors of the type 1 glycine transporter
John A Lowe, Shari L Deninno, Susan E Drozda, et al.
ACS Chemical Biology
|
October 9, 2014
Chemoproteomics demonstrates target engagement and exquisite selectivity of the clinical phosphodiesterase 10A inhibitor MP-10 in its native environment
Jan-Philip Schülke, Laura A McAllister, Kieran F Geoghegan, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
July 26, 2006
Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species
Timothy M Coskran, Daniel Morton, Frank S Menniti, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 10, 2015
Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways
Fernando E Padovan-Neto, Stephen Sammut, Shreaya Chakroborty, et al.
Neuropharmacology
|
June 20, 2006
Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis
Judith A Siuciak, Douglas S Chapin, John F Harms, et al.
Brain Research
|
January 22, 2019
In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [<sup>18</sup>F]MNI-659
Marie M Svedberg, Katarina Varnäs, Andrea Varrone, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 7, 2010
Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's disease
Robin J Kleiman, Lida H Kimmel, Susan E Bove, et al.
Neuropharmacology
|
June 14, 2006
Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function
Judith A Siuciak, Sheryl A McCarthy, Douglas S Chapin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 2013
Positive allosteric modulation of AMPA receptors from efficacy to toxicity: the interspecies exposure-response continuum of the novel potentiator PF-4778574
Christopher L Shaffer, Raymond S Hurst, Renato J Scialis, et al.
Journal of Medicinal Chemistry
|
January 19, 2007
Discovery of a series of 6,7-dimethoxy-4-pyrrolidylquinazoline PDE10A inhibitors
Thomas A Chappie, John M Humphrey, Martin P Allen, et al.
Page
of 5